메뉴 건너뛰기




Volumn 25, Issue 2, 2007, Pages 101-109

Survival benefit for early hormone ablation in biochemically recurrent prostate cancer

Author keywords

Androgen ablation; Biochemical recurrence; Prostate cancer; PSA

Indexed keywords

ANTIANDROGEN; DIETHYLSTILBESTROL; PROSTATE SPECIFIC ANTIGEN;

EID: 33847360906     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2006.03.002     Document Type: Article
Times cited : (18)

References (24)
  • 1
    • 84928580276 scopus 로고
    • Studies on prostate cancer: I. The effect of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
    • Huggins C., and Hodges C.V. Studies on prostate cancer: I. The effect of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1 (1941) 293-297
    • (1941) Cancer Res , vol.1 , pp. 293-297
    • Huggins, C.1    Hodges, C.V.2
  • 2
    • 0034659787 scopus 로고    scopus 로고
    • Hormone therapy for patients with prostate carcinoma
    • Klotz L. Hormone therapy for patients with prostate carcinoma. Cancer 88 (2000) 3009-3014
    • (2000) Cancer , vol.88 , pp. 3009-3014
    • Klotz, L.1
  • 3
    • 0142248845 scopus 로고    scopus 로고
    • Variables in predicting survival based on treating "PSA-only" relapse
    • Moul J.W. Variables in predicting survival based on treating "PSA-only" relapse. Urol Oncol 21 (2003) 292-304
    • (2003) Urol Oncol , vol.21 , pp. 292-304
    • Moul, J.W.1
  • 5
    • 0033540004 scopus 로고    scopus 로고
    • Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
    • Messing E.M., Manola J., Sarosdy M., et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
    • (1999) N Engl J Med , vol.341 , pp. 1781-1788
    • Messing, E.M.1    Manola, J.2    Sarosdy, M.3
  • 6
    • 0031403675 scopus 로고    scopus 로고
    • Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial
    • The Medical Research Council Prostate Cancer Working Party Investigators Group
    • The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial. Br J Urol 79 (1997) 235-246
    • (1997) Br J Urol , vol.79 , pp. 235-246
  • 7
    • 0037298718 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network guidelines for the management of prostate cancer
    • Scherr D., Swindle P.W., and Scardino P.T. National Comprehensive Cancer Network guidelines for the management of prostate cancer. Urology 61 (2003) 14-24
    • (2003) Urology , vol.61 , pp. 14-24
    • Scherr, D.1    Swindle, P.W.2    Scardino, P.T.3
  • 8
    • 0030827106 scopus 로고    scopus 로고
    • Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer
    • Zagars G.K., and Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol 44 (1997) 213-221
    • (1997) Radiother Oncol , vol.44 , pp. 213-221
    • Zagars, G.K.1    Pollack, A.2
  • 9
    • 0033526309 scopus 로고    scopus 로고
    • Natural history of progression after PSA elevation following radical prostatectomy
    • Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
    • (1999) JAMA , vol.281 , pp. 1591-1597
    • Pound, C.R.1    Partin, A.W.2    Eisenberger, M.A.3
  • 10
    • 0028198996 scopus 로고
    • Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: Early versus delayed treatment
    • McCarthy J.F., Catalona W.J., and Hudson M.A. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: Early versus delayed treatment. J Urol 151 (1994) 1575-1578
    • (1994) J Urol , vol.151 , pp. 1575-1578
    • McCarthy, J.F.1    Catalona, W.J.2    Hudson, M.A.3
  • 11
    • 0036603607 scopus 로고    scopus 로고
    • Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer
    • Hanlon A.L., Diratzouian H., and Hanks G.E. Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 297-303
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , pp. 297-303
    • Hanlon, A.L.1    Diratzouian, H.2    Hanks, G.E.3
  • 12
    • 0031014008 scopus 로고    scopus 로고
    • Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations
    • Lee W.R., Hanks G.E., and Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations. J Clin Oncol 15 (1997) 230-238
    • (1997) J Clin Oncol , vol.15 , pp. 230-238
    • Lee, W.R.1    Hanks, G.E.2    Hanlon, A.3
  • 13
    • 0027202228 scopus 로고
    • Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time
    • Hanks G.E., D'Amico A., Epstein B.E., et al. Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time. Int J Radiat Oncol Biol Phys 27 (1993) 125-127
    • (1993) Int J Radiat Oncol Biol Phys , vol.27 , pp. 125-127
    • Hanks, G.E.1    D'Amico, A.2    Epstein, B.E.3
  • 14
    • 0033973235 scopus 로고    scopus 로고
    • Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate
    • DeWeese T.L., and Song D.Y. Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate. Urology 55 (2000) 169-174
    • (2000) Urology , vol.55 , pp. 169-174
    • DeWeese, T.L.1    Song, D.Y.2
  • 15
    • 0002646642 scopus 로고    scopus 로고
    • Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?
    • Pollack A., and Zagars G.K. Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?. Semin Radiat Oncol 8 (1998) 95-106
    • (1998) Semin Radiat Oncol , vol.8 , pp. 95-106
    • Pollack, A.1    Zagars, G.K.2
  • 16
    • 0037335351 scopus 로고    scopus 로고
    • Quality of life following definitive therapy for localized prostate cancer: Potential impact of multiple therapies
    • Litwin M.S. Quality of life following definitive therapy for localized prostate cancer: Potential impact of multiple therapies. Curr Opin Urol 13 (2003) 153-156
    • (2003) Curr Opin Urol , vol.13 , pp. 153-156
    • Litwin, M.S.1
  • 17
    • 0030906817 scopus 로고    scopus 로고
    • Consensus statement guidelines for PSA following radiation therapy
    • American Society for Therapeutic Radiation and Oncology (ASTRO)
    • American Society for Therapeutic Radiation and Oncology (ASTRO). Consensus statement guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
    • (1997) Int J Radiat Oncol Biol Phys , vol.37 , pp. 1035-1041
  • 18
    • 0035667653 scopus 로고    scopus 로고
    • Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
    • Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843-848
    • (2001) Urology , vol.58 , pp. 843-848
    • Partin, A.W.1    Mangold, L.A.2    Lamm, D.M.3
  • 19
    • 0031051097 scopus 로고    scopus 로고
    • Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31
    • Pilepich M.V., Caplan R., Byhardt R.W., et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol 15 (1997) 1013-1021
    • (1997) J Clin Oncol , vol.15 , pp. 1013-1021
    • Pilepich, M.V.1    Caplan, R.2    Byhardt, R.W.3
  • 20
    • 0030856678 scopus 로고    scopus 로고
    • Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
    • Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
    • (1997) N Engl J Med , vol.337 , pp. 295-300
    • Bolla, M.1    Gonzalez, D.2    Warde, P.3
  • 21
    • 0032412702 scopus 로고    scopus 로고
    • Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: A prospective randomized study
    • Granfors T., Modig H., Damber J.E., et al. Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: A prospective randomized study. J Urol 159 (1998) 2030-2034
    • (1998) J Urol , vol.159 , pp. 2030-2034
    • Granfors, T.1    Modig, H.2    Damber, J.E.3
  • 22
    • 0028229803 scopus 로고
    • Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer
    • Pollack A., Zagars G.K., and Kavadi V.S. Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer 74 (1994) 670-678
    • (1994) Cancer , vol.74 , pp. 670-678
    • Pollack, A.1    Zagars, G.K.2    Kavadi, V.S.3
  • 23
    • 0034904071 scopus 로고    scopus 로고
    • The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: A survey of practice patterns of urologists and radiation oncologists in the United States
    • Sylvester J., Grimm P., Blasco J., et al. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: A survey of practice patterns of urologists and radiation oncologists in the United States. Urology 58 (2001) 65-70
    • (2001) Urology , vol.58 , pp. 65-70
    • Sylvester, J.1    Grimm, P.2    Blasco, J.3
  • 24
    • 12144290450 scopus 로고    scopus 로고
    • Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy
    • Moul J.W., Wu H., Sun L., et al. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol 171 (2004) 1141-1147
    • (2004) J Urol , vol.171 , pp. 1141-1147
    • Moul, J.W.1    Wu, H.2    Sun, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.